News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Foto: Matthew Reeves/cortesía de The Hand & The Eye]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/21113551/01-91529348-the-hand-and-the-eye.webp)
![[Imágenes: Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/21110116/p-1-91529459-stop-outsourcing-your-judgement-brene-brown.webp)
![[Fotos: Justin Sullivan/Getty Images; Norbert Braun/Unsplash;
Dithira Hettiarachchi/Unsplash]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/21134917/Tim-Cook-Apple-Fast-Company-Mexico-Cortesia.webp)
![[Fotos: ArieStudio/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/21123649/Afresh-desperdicio-comida-IA-Fast-Company-Mexico-Cortesia.webp)
